Work

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts

Year: 2021

Type: article

Abstract: IRDye800CW-AE344 is a promising uPAR-targeted optical probe for FGS and a candidate for translation into human use.

Source: Theranostics

DOI: 10.7150/thno.49787

Authors: Sorel Kurbegovic, Karina Juhl, Kasper Kildegaard Sørensen, Julie Leth, Gro Linno Willemoe, Anders Christensen, Yvonne Adams, Anja Ramstedt Jensen, Christian von Buchwald, Jane Skjøth-Rasmussen, Michael Ploug, Knud J. Jensen, Andreas Kjaer

Institutions: University of Copenhagen, Rigshospitalet, Copenhagen University Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,671

Funders: Arvid Nilssons Fond, Innovationsfonden, European Commission, National Research Foundation, Danmarks Grundforskningsfond, Lundbeckfonden, Novo Nordisk, Rigshospitalet, Region Hovedstaden, H. Lundbeck A/S, Kemisk Institut, Københavns Universitet

Awards: G190953956, G1944617807, G3883432169, G5857062797, “In Vivo Click PET Imaging Agents”: Improving clinical companion diagnostics, G8420224504, G8537674695

OpenAlex ID: W3166119499

FWCI: 2.246

Cites: 53

Cited by: 33

Related to: 10